Achieve Life Sciences (ACHV) Non Operating Income (2010 - 2026)
Achieve Life Sciences (ACHV) posted Non Operating Income of $295000.0 for Q1 2026, up 327.54% on a QoQ basis from $69000.0 in Q4 2025, and up 340.3% year-over-year from $67000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Non Operating Income (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Non Operating Income history runs 17 years deep, the most recent figure standing at $295000.0 for Q1 2026.
- Quarterly Non Operating Income rose 340.3% year-over-year to $295000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $460000.0 (up 356.98% YoY) and the FY2025 annual result came in at $232000.0, up 130.61% from the prior year.
- Non Operating Income was $295000.0 for Q1 2026 at Achieve Life Sciences, up from $69000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $295000.0 in Q1 2026 and bottomed at -$1.1 million in Q4 2023.
- A 5-year average of -$255647.1 and a median of -$347000.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income plunged 22000.0% — and 2025, when it surged 645.65%.
- Achieve Life Sciences' Non Operating Income stood at -$370000.0 in 2022, then plunged by 194.59% to -$1.1 million in 2023, then surged by 84.4% to -$170000.0 in 2024, then soared by 140.59% to $69000.0 in 2025, then soared by 327.54% to $295000.0 in 2026.
- Business Quant data shows ACHV's Non Operating Income at $295000.0 in Q1 2026, $69000.0 in Q4 2025, and $251000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | 295,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 295,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Jun 30, 2025 | -155,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | -170,000.00 |
| Sep 30, 2024 | -46,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | -536,000.00 |
| Jun 30, 2023 | -525,000.00 |
| Mar 31, 2023 | -414,000.00 |
| Dec 31, 2022 | -370,000.00 |
| Sep 30, 2022 | -438,000.00 |
| Jun 30, 2022 | -395,000.00 |
| Mar 31, 2022 | -347,000.00 |
| Dec 31, 2021 | -36,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -9,000.00 |